Abstract | OBJECTIVES: To compare mutations in the quinolone resistance-determining region of the gyrA gene and flanking sequences with the MICs of ofloxacin and moxifloxacin for Mycobacterium tuberculosis. METHODS: The presence of mutations in 177 drug-resistant M. tuberculosis isolates was determined by DNA sequencing and the MICs quantified by MGIT 960. RESULTS: Single nucleotide polymorphisms were detected at codons 94 ( n = 30), 90 (n = 12), 91 (n = 3), 89 (n = 1), 88 (n = 1) and 80 (n = 1). Four isolates with double mutations D94G plus A90V (n = 2) and D94G plus D94N (n = 2) reflect mixed populations. Agreement between genotypic and phenotypic susceptibility was high (≥97%) for both drugs. Mutant isolates had an MIC(50) of 8.0 mg/L and an MIC(90) of >10 mg/L for ofloxacin compared with an MIC(50) and MIC(90) of 2.0 mg/L for moxifloxacin. Codons 94 and 88 were linked to higher levels of fluoroquinolone resistance compared with codons 90, 91 and 89. The MIC distributions for the wild-type isolates ranged from ≤0.5 to 2.0 mg/L for ofloxacin and from ≤0.125 to 0.25 mg/L for moxifloxacin. However, 96% of the isolates with genetic alterations had MICs ≤2.0 mg/L for moxifloxacin, which is within its achievable serum levels. CONCLUSIONS:
|
Authors | Frederick A Sirgel, Robin M Warren, Elizabeth M Streicher, Thomas C Victor, Paul D van Helden, Erik C Böttger |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 67
Issue 5
Pg. 1088-93
(May 2012)
ISSN: 1460-2091 [Electronic] England |
PMID | 22357804
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antitubercular Agents
- Aza Compounds
- Fluoroquinolones
- Quinolines
- Ofloxacin
- DNA Gyrase
- Moxifloxacin
|
Topics |
- Antitubercular Agents
(pharmacology)
- Aza Compounds
(pharmacology)
- DNA Gyrase
(genetics)
- Drug Resistance, Bacterial
- Fluoroquinolones
- Humans
- Microbial Sensitivity Tests
- Moxifloxacin
- Mutation, Missense
- Mycobacterium tuberculosis
(drug effects, genetics)
- Ofloxacin
(pharmacology)
- Polymorphism, Single Nucleotide
- Quinolines
(pharmacology)
|